Načítá se...
Why will it never be known if convalescent plasma is effective for COVID-19
High expectations have been set around convalescent plasma (CP) for the treatment of COVID-19. However, none of the randomized controlled trials (RCTs) conducted so far have reached their primary endpoints. Herein we report that RCTs of CP disclose a high methodological variability in inclusion crit...
Uloženo v:
| Vydáno v: | J Transl Autoimmun |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7641519/ https://ncbi.nlm.nih.gov/pubmed/33169114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtauto.2020.100069 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|